Keresty Georgia Insider Trades

Insider Trading History

Track insider trading activity for Keresty Georgia. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $746k 77,500 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$512k 77,500 shares
$6.61
$9.62
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $536k 41,083 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 22,500 shares
$12.89
$13.04
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $746k 77,500 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$355k 77,500 shares
$4.58
$9.62
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $416k 31,883 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$95.8k 11,450 shares
$8.37
$13.04
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $311k 23,883 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$298k 11,515 shares
$25.85
$13.04
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $331k 34,400 shares
Last Trade
Jun 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$258k 34,400 shares
$7.51
$9.62
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $211k 16,146 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$293k 6,473 shares
$45.20
$13.04
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $92.8k 9,650 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.5k 9,650 shares
$6.37
$9.62
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $92.8k 9,650 shares
Last Trade
Dec 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.4k 9,650 shares
$6.47
$9.62
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $100k 7,688 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$296k 7,688 shares
$38.49
$13.04
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $491k 51,000 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$478k 51,000 shares
$9.38
$9.62
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $85.1k 6,524 shares
Last Trade
Jun 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$212k 2,534 shares
$83.59
$13.04
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $44.1k 3,382 shares
Last Trade
Jun 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$458k 5,476 shares
$83.59
$13.04
Intellia Therapeutics
Intellia Therapeutics NTLA
Director
Holding Value $101k 7,755 shares
Last Trade
Apr 09, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$898k 12,710 shares
$70.64
$13.04
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $385k 40,000 shares
Last Trade
Mar 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.43M 40,000 shares
$160.80
$9.62

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up